Pfizer: Still Mispriced By Mr. Market (Earnings Preview) (NYSE:PFE)
· seekingalpha.com
Pfizer is a Buy, with a 16% nominal upside and ~7% dividend yield, driven by a diversified, expanding product portfolio. Read more on PFE stock here.
Now you can get access to the latest and highest-quality analysis of recent Wall Street buying and selling ideas with just one subscription to Beyond the Wall I...